U.S. SECURITIES AND EXCHANGE COMMISSION


     Litigation Release No. 15651 / February 24 , 1998

     SECURITIES AND EXCHANGE COMMISSION v. DAVID A. COLVIN; INTELLINET
     PUBLISHING, INC.;  INTELLINET HOLDING GROUP, INC.; MEDICAL ADVANTAGE, INC.;
     LAMELLI, INC., a/k/a LAMELLI MEDICAL TECHNOLOGY, INC.; WALL STREET RESEARCH
     COMPANY, INC.; JOB KJELL HOVIK; LAMAR ELLIS; and JOHN LARSON, a/k/a  JOHN
     ST. JOHN, Civil Action No. SACV 98-135 AHS (EEx) (C.D. Cal.)

          On February 20, 1998, the Securities and Exchange Commission filed an
     emergency lawsuit shutting down a Southern California boiler room which was
     deceiving investors into believing that former U.S. Surgeon General C.
     Everett Koop and NBC television journalist Tom Brokaw had endorsed one of
     the defendants  companies.  The scheme, which has bilked investors out of
     more than $5 million since January 1997, employed high pressure
     telemarketing sales techniques and used Dr. Koop s likeness and quotations
     on an Internet website to fraudulently sell securities.  

          The individual defendants, David A. Colvin, 54, of Chatsworth,
     California, Job Kjell Hovik, of Carlsbad, California, Lamar Ellis, of
     Pomona, California and John Larson (a/k/a John St. John) of Los Angeles,
     California, used a Canoga Park boiler room, Intellinet Publishing, Inc., to
     sell securities in an obesity clinic company, Medical Advantage, Inc. and
     an alcohol and drug detoxification company, Lamelli, Inc.  Another firm,
     Wall Street Research Company, Inc., which purports to do investment
     research, issued fraudulent  buy  recommendations for Medical Advantage. 

          In its lawsuit, the Commission alleges that the defendants falsely
     claimed that Dr. Koop and Mr. Brokaw were affiliated with the Medical
     Advantage obesity clinics and that Mr. Brokaw would be the company s
     infomercial spokesperson.  The Commission further alleges that investors
     were falsely promised the return of their principal investment, plus 12%
     interest, in 120 to 180 days.  Instead, Colvin, who masterminded the
     scheme, misappropriated investor funds, using most of the money for boiler
     room expenses and for his other business ventures.  Among the other
     misrepresentations alleged, the defendants falsely claimed that Medical
     Advantage and Lamelli would become public companies in 120 to 180 days. 
     The defendants further claimed that Lamelli had built and leased 250
     detoxification units and expected $37 million in revenues in the first
     quarter of 1998.  In fact, Medical Advantage and Lamelli are not public
     companies.  Further, Lamelli does not have any completed detoxification
     units or lease agreements and has yet to generate any revenue.  In
     addition, Colvin concealed his ownership of Wall Street Research and
     deceived investors into believing that its buy recommendations for Medical
     Advantage were the result of independent and impartial investment research.


          In the lawsuit, which was filed in the United States District Court
     for the Central District of California, the Commission obtained an order
     freezing the assets of the defendants, appointing a receiver to preserve

                              ======END OF PAGE 1======







     investor assets and temporarily enjoining the defendants from future
     violations of Section 5(a), 5(c) and 17(a) of the Securities Act of 1933
     and Sections 10(b) and 15(a) of Securities Exchange Act of 1934 and Rule
     10b-5 thereunder.  The Commission also seeks preliminary and permanent
     injunctions, and other relief, including disgorgement and civil penalties
     against the defendants.















































                              ======END OF PAGE 2======